Apolipoprotein E4 in Parkinson disease and dementia: New data and meta-analysis of published studies

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 1, 1998, Pages 45-48

  Inzelberg, Rivka ^a,b   Chapman, J ^a   Treves, T A ^a   Asherov, A ^a   Kipervasser, S ^a   Hilkewicz, O ^a   Verchovsky, R ^a   Klimowitzky, S ^a   Korczyn, A D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

Author keywords

Apolipoprotein E; Dementia; Genotyping; Meta analysis; Parkinson's disease

Indexed keywords

APOLIPOPROTEIN E4; DNA; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROCHEMISTRY; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032466990     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199803000-00007     Document Type: Article

References (22)

1. Asherov A, Chapman J, Kipervasser S, et al. ApoE4 haplotype in Parkinson's disease (PD) and its relation to dementia [abstract]. Neurology 1995;45(Suppl4):A340.
2. Benjamin R, Leake A, Edwardson JA, et al. Apolipoprotein E genes in Lewy body and Parkinson's disease [letter]. Lancet 1994;343:1565.
3. Brown RG, Marsden CD. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci 1990;13:21-9.
4. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-7.
5. Chapman J, Estupinian J, Asherov A, Goldfarb LG. A simple and efficient method for apolipoprotein genotype determination. Neurology 1996;46:1484-5.
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
7. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ∈4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1.
8. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995;37:242-5.
9. Korczyn AD, Inzelberg R, Treves T, et al. Dementia of Parkinson's disease. Adv Neurol 1986;45:393-7.
10. Korczyn AD. The apolipoprotein ∈4 allele in Parkinson's disease with and without dementia [letter]. Neurology 1995;45:1025.
11. Korczyn AD, ed. Dementia in Parkinson's disease. Bologna, Italy: Monduzzi, 1995.
12. Marder K, Maestre G, Cote L, et al. The apolipoprotein ∈4 allele in Parkinson's disease with and without dementia. Neurology 1994;44:1330-1.
13. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Arch Neurol 1992;49:492-7.
14. Pickering-Brown SM, Mann DMA, Bourke JP, et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid forming diseases. Lancer 1994;343:1155.
15. Riggs JE, Keefover RW. The association between apolipoprotein E allele ∈4 and late-onset Alzheimer's disease: pathogenic relationship or differential bias [letter]. Arch Neurol 1994;51:750.
16. Rubinsztein DC, Hanlon CS, Irving RM, et al. ApoE genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes 1994;8:519-25.
17. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
18. Treves TA, Ragolsky M, Gelentner I, et al. Evaluation of a short mental test for the diagnosis of dementia. Dementia 1990;1:102-8.
19. Treves TA, Asherov A, Chapman J, et al. ApoE haplotypes in vascular dementia. Neurology 1995;45(suppl 4):A469-70.
20. van Bockxmeer FM, Mamotte CDS. Apolipoprotein ∈4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-80.
21. Wenham PR, Price WH, Blundel G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
22. Whitehouse PJ. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert. In Parkinson's disease and Alzheimer's disease. Adv Neurol 1986;45:393-7.